ClinicalTrials.gg
Not yet recruitingNCT07774260Updated Aug 19, 2026

Efficacy Validation of Deep Microspicule Cream for Anti-aging and Whitening on Mature Skin

An interventional study of Deep Microspicule Cream in Efficacy Validation of Deep Microspicule Cream for Anti-aging and Whitening on Mature Skin, sponsored by Chung Shan Medical University. Not yet recruiting at 1 site in Taiwan. Open to participants aged 40 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Chung Shan Medical University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
40 Years to 65 Years
Sex
All
01

Study summary

This study is a single-center, prospective, split-face self-controlled pilot trial designed to evaluate the anti-aging and whitening efficacy of the "Deep Microspicule Cream" (containing patented crystal microspicules encapsulating Penghu seaweed extract) on mature skin.

Read the detailed description

This study is a single-center, prospective, split-face self-controlled pilot trial.

10 healthy participants aged 40-65 who present signs of skin aging or hyperpigmentation will be enrolled.

Intervention Side (Active): Participants will apply a green-bean-sized amount of Deep Microspicule Cream on the assigned side, gently massaging to let the microspicules roll on the skin, followed by the application of Deep Essence to dissolve the microspicules.

Control Side: Participants will apply Deep Essence only. The applications are performed 3 times per week at bedtime. Clinical evaluations and instrument measurements are scheduled at Day 0 (baseline), Day 14, and Day 28. On assessment days, participants must cleanse their faces and rest in a controlled environment for 25-30 minutes without applying any cosmetics before undergoing non-invasive skin assessments.

02

Conditions studied

  • Efficacy Validation of Deep Microspicule Cream for Anti-aging and Whitening on Mature Skin

Keywords

  • Microspicule, Anti-aging, Whitening
03

In context

Lead sponsor

Chung Shan Medical University is the lead sponsor of 125 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy male or female participants aged 40-65 years.
  • Presence of at least one facial aging or hyperpigmentation feature (e.g., eye area sagging, eye bags, crow's feet, fine lines, freckles, sun spots, uneven skin tone, or dullness).
  • Willing to complete 3 study visits within 4 weeks, comply with instrumental measurements, and maintain product logs.
  • Willing to sign the Form (ICF).

Exclusion criteria

Exclusion Criteria:

  • Received facial aesthetic treatments (e.g., lasers, chemical peels, microneedling, energy-based therapies) within 4 weeks.
  • Used topical/oral retinoic acid or strong whitening creams (e.g., high-concentration hydroquinone) within 4 weeks.
  • Severe sensitive skin, active atopic dermatitis, or obvious facial skin lesions/infections.
  • Facial salon or exfoliation treatments more frequent than once every 2 weeks.
  • Known allergy to seaweed-derived ingredients or product preservative systems.
  • Uncontrolled systemic diseases (e.g., diabetes, kidney/liver/cardiovascular diseases, severe infections, endocrine disorders, or cancer).
  • Pregnant, lactating, or planning to become pregnant.
  • Deemed unsuitable for participation by the investigator.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Split-Face Control Group

    "All 10 participants in this group will undergo two different skincare regimens on randomly assigned sides of the face (left or right) for a duration of 28 days. On the designated intervention side, participants will apply a green-bean-sized amount of Deep Microspicule Cream and gently massage, followed by the application of Deep Essence to dissolve the microspicules. On the opposite control side, participants will apply Deep Essence only as a within-subject control. Both regimens are to be applied three times per week (Mondays, Wednesdays, and Saturdays) at night after cleansing.

    Other: Deep Microspicule Cream

Interventions

  • OtherDeep Microspicule Cream

    "A topical cream (Deep Microspicule Cream) utilizing patented crystal microspicule technology to encapsulate Penghu seaweed extracts (including Caulerpa microphysa, Sargassum hemiphyllum, and Botryocladia leptopoda). These ingredients possess potential anti-inflammatory, antioxidant, and collagen-promoting properties. Participants will apply a green-bean-sized amount of the cream strictly to the randomly assigned intervention side of the face (left or right). The cream should be massaged gently on the designated side to allow the microspicules to roll on the skin surface (avoiding harsh rubbing). This application regimen is to be performed three times per week (Mondays, Wednesdays, and Saturdays) at night after facial cleansing, for a total duration of 28 days."

06

What researchers measure

Primary outcomes

  1. Skin Hydration,Transepidermal Water Loss (TEWL),Skin Elasticity,Erythema Index,Skin Color

    "Using the Cutometer® MPA 580 to sequentially measure skin hydration, transepidermal water loss (TEWL), skin elasticity, erythema index, and skin color."

    Time frame: Baseline (Day 0), Day 14, Day 28

Secondary outcomes

  1. skin texture smoothness, visual radiance (glossiness), and skin firmness

    "Subjective evaluation of skin improvement including skin feel (texture smoothness), visual radiance (glossiness), and skin firmness, assessed via a 7-point Likert scale (ranging from 1 = very dissatisfied to 7 = very satisfied) .

    Time frame: Baseline (Day 0), Day 14, Day 28

07

Study locations

1 site
08

References and documents

Publications

  • Nawaz T, Shin J, Shieh M, Yoo JY. A Split-Face Micro-Needling Study to Evaluate the Efficacy and Consumer Perception of a Novel Moisturization Agent. J Cosmet Dermatol. 2025 Mar;24(3):e70109. doi: 10.1111/jocd.70109. PubMed 40099382 ↗
  • Friedman O. Changes associated with the aging face. Facial Plast Surg Clin North Am. 2005 Aug;13(3):371-80. doi: 10.1016/j.fsc.2005.04.004. PubMed 16085282 ↗
  • Zouboulis CC, Makrantonaki E. Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol. 2011 Jan-Feb;29(1):3-14. doi: 10.1016/j.clindermatol.2010.07.001. PubMed 21146726 ↗
  • 2. M. B. Ariede, T. M. Candido, A. L. M. Jacome, M. V. R. Velasco, J. C. M. de Carvalho, and A. R. Baby, Cosmetic attributes of algae - A review. Algal Research 2017, 25, 483-487.
  • Farage MA, Miller KW, Elsner P, Maibach HI. Intrinsic and extrinsic factors in skin ageing: a review. Int J Cosmet Sci. 2008 Apr;30(2):87-95. doi: 10.1111/j.1468-2494.2007.00415.x. PubMed 18377617 ↗
  • Lu KY, Cheng LC, Hung ZC, Chen ZY, Wang CW, Hou HH. The Ethyl Acetate Extract of Caulerpa microphysa Promotes Collagen Homeostasis and Inhibits Inflammation in the Skin. Curr Issues Mol Biol. 2024 Mar 21;46(3):2701-2712. doi: 10.3390/cimb46030170. PubMed 38534786 ↗
  • Rocha DHA, Pinto DCGA, Silva AMS. Macroalgae Specialized Metabolites: Evidence for Their Anti-Inflammatory Health Benefits. Mar Drugs. 2022 Dec 19;20(12):789. doi: 10.3390/md20120789. PubMed 36547936 ↗
  • Thomas R, Wang W, Su DM. Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging. Immun Ageing. 2020 Jan 20;17:2. doi: 10.1186/s12979-020-0173-8. eCollection 2020. PubMed 31988649 ↗
  • Bocheva GS, Slominski RM, Slominski AT. Immunological Aspects of Skin Aging in Atopic Dermatitis. Int J Mol Sci. 2021 May 27;22(11):5729. doi: 10.3390/ijms22115729. PubMed 34072076 ↗
  • Fitsiou E, Pulido T, Campisi J, Alimirah F, Demaria M. Cellular Senescence and the Senescence-Associated Secretory Phenotype as Drivers of Skin Photoaging. J Invest Dermatol. 2021 Apr;141(4S):1119-1126. doi: 10.1016/j.jid.2020.09.031. Epub 2020 Dec 19. PubMed 33349436 ↗
  • Goldberg EL, Dixit VD. Drivers of age-related inflammation and strategies for healthspan extension. Immunol Rev. 2015 May;265(1):63-74. doi: 10.1111/imr.12295. PubMed 25879284 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07774260
Responsible party
Sponsor
First posted
Aug 19, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Oct 30, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
Aug 19, 2026

Study contacts

You-Cheng Mr Shen, Ph.D.
Contact
youcheng@csmu.edu.tw
886-4-24730022 ext. 12107

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion